DSPAMC-HEALTHADD (NSE: HEALTHADD, BSE: 544109) is a Mumbai, Maharashtra-based company in the Investment Funds industry. With a market capitalisation of ₹0 Cr, it ranks #5,283 by market cap among the 6,197 Indian listed companies on FinBizNet, and #75 of 360 in Investment Funds. At ₹17.34 (as of 16 Nov 2026), the share price is 89.5% below its 52-week high of ₹165.86 and 14.0% above its 52-week low of ₹15.21. The share price is down 88.4% over one year and up 4.3% over three months.
| Current Price | ₹17.34 |
|---|---|
| Market Cap | ₹0 Cr |
| NSE Symbol | HEALTHADD |
| BSE Code | 544109 |
| Sector | Financials > Financial Services > Capital Markets |
| Sub-Industry | Asset Management and Custody Banks > Investment Funds |
| 52-Week Range | ₹15.21 – ₹165.86 |
| 1-Year Price Change | -88.4% |
| 3-Month Price Change | +4.3% |
| Headquarters | Mumbai, Maharashtra |
1. NA-NA 2. NA-NA 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| NIPPONAMC - SNXT30BEES | ₹7 Cr | — | — | — | +10.8% |
| NIPINDETFINFRABEES | ₹0 Cr | — | — | — | +1.0% |
| Reliance Mutual Fund-Permitted-JUNIORBEES | ₹0 Cr | — | — | — | +4.7% |
| NIPINDETFSHARIAHBEES | ₹0 Cr | — | — | — | -7.0% |
| NIPINDETFNIFTYBEES | ₹0 Cr | — | — | — | -0.6% |
| NIPINDETFETFNV20 | ₹0 Cr | — | — | — | -2.8% |
| Nippon India Mutual Fund-SNXT50BEES | ₹0 Cr | — | — | — | +1.7% |
| NIPINDETFDIVOPP | ₹0 Cr | — | — | — | -2.8% |
| DSPAMC-HEALTHADD | ₹0 Cr | — | — | — | -88.4% |
Listed by market capitalisation. Ratios are shown for context only.
DSPAMC-HEALTHADD is trading at ₹17.34, with a market capitalisation of ₹0 Cr.
DSPAMC-HEALTHADD operates in the Financials > Financial Services > Capital Markets space (Asset Management and Custody Banks > Investment Funds).
DSPAMC-HEALTHADD is listed on the NSE under the symbol HEALTHADD and on the BSE under the scrip code 544109.
DSPAMC-HEALTHADD's share price is down 88.4% over one year and up 4.3% over three months. Its 52-week range is ₹15.21 to ₹165.86.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.